Excess Returns  cover image

Mike Green and Mike Taylor | PNL For a Purpose

Excess Returns

00:00

Healthcare Innovation Portfolio Strategy and Focus on Sorepta Gene Therapy Company

Exploring the investment thesis behind Sarepta, a gene therapy company focused on Duchenne's muscular dystrophy treatment, and the strategic approach to healthcare innovation investments for asymmetric returns.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app